Dr. David L. Bartlett

Matthew Holtzman, MD, is a surgical oncologist specializing in the treatment of colorectal, liver, GI cancers, as well as melanoma and sarcoma. In addition to traditional surgery, Dr. Holtzman specializes in Minimally Invasive surgical approaches to cancer treatment. As part of the David C. Koch Regional Perfusion Cancer Therapy Center, Dr. Holtzman's team performs many specialized concentrated regional chemotherapy and radiotherapy procedures to treat advanced malignancies. His research interests include the treatment of recurrent cancers, regional radiation therapies, and novel treatments for melanoma. Dr. Holtzman is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Pseudomyxoma Peritonei, Melanoma, Colorectal Cancer, Splenectomy, and Hernia Surgery.

James F. Pingpank Jr., MD, is an associate professor of surgery at the University of Pittsburgh School of Medicine. Dr. Pingpank specializes in regional treatment strategies for advance malignancies of the liver and peritoneal cavity. Dr. Pingpank is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Neuroendocrine Tumor, Liver Embolization, and Hernia Surgery.

Amer H. Zureikat, MD, is vice chair of surgery for surgical oncology in the Department of Surgery at UPMC, chief of Surgical Oncology at UPMC Hillman Cancer Center, and UPMC Chair of Clinical Surgery. He is the division chief for gastrointestinal surgical oncology in the Department of Surgery at UPMC and professor of surgery at the University of Pittsburgh School of Medicine. Dr. Zureikat specializes in cancers and diseases of the pancreas, stomach, liver and duodenum and is an expert in robotic pancreatic surgery. His clinical and academic interests include the multimodality treatment of pancreatic cancer, and comparative effectiveness of open and robotic approaches to gastrointestinal cancers in general and pancreatic cancer in particular. Dr. Zureikat is board-certified in general surgery. He received his medical degree from the Royal College of Surgeons in Dublin, Ireland, completed his general surgery residency at the University of Chicago Medical Center and his fellowship in surgical oncology at the University of Pittsburgh/UPMC. Dr. Zureikat is a member of the Society of University Surgeons (SUS), Society of Surgical Oncology (SSO), and the Americas Hepato-Pancreato-Biliary Association (AHPBA). In addition, he is a fellow of the American College of Surgeons (ACS). Dr. Zureikat is rated as an Elite provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Pancreatic Cancer, Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.